These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 29173061)
1. Targeted Sequencing of Malignant Supratentorial Pediatric Brain Tumors Demonstrates a High Frequency of Clinically Relevant Mutations. Cole BL; Pritchard CC; Anderson M; Leary SE Pediatr Dev Pathol; 2018; 21(4):380-388. PubMed ID: 29173061 [TBL] [Abstract][Full Text] [Related]
2. Tumor mutational burden and driver mutations: Characterizing the genomic landscape of pediatric brain tumors. Patel RR; Ramkissoon SH; Ross J; Weintraub L Pediatr Blood Cancer; 2020 Jul; 67(7):e28338. PubMed ID: 32386112 [TBL] [Abstract][Full Text] [Related]
3. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743 [TBL] [Abstract][Full Text] [Related]
4. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact. Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238 [TBL] [Abstract][Full Text] [Related]
5. Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors. Ronsley R; Karvonen KA; Cole B; Paulson V; Stevens J; Crotty EE; Hauptman J; Lee A; Stasi SM; Lockwood CM; Leary SES J Neurooncol; 2024 Jun; 168(2):215-224. PubMed ID: 38755519 [TBL] [Abstract][Full Text] [Related]
6. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA]. Pécuchet N; Legras A; Laurent-Puig P; Blons H Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564 [TBL] [Abstract][Full Text] [Related]
8. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing. Andersson C; Fagman H; Hansson M; Enlund F Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750 [TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of pediatric and adolescent ependymomas: identification of genetic variants using a next-generation sequencing panel. Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Benevides Silva FA; Dastoli PA; Cavalheiro S; Caminada de Toledo SR J Neurooncol; 2021 Oct; 155(1):13-23. PubMed ID: 34570300 [TBL] [Abstract][Full Text] [Related]
11. Germline Genetic Features of Young Individuals With Colorectal Cancer. Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522 [TBL] [Abstract][Full Text] [Related]
12. Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors. Lee JW; Kim NKD; Lee SH; Cho HW; Ma Y; Ju HY; Yoo KH; Sung KW; Koo HH; Park WY PLoS One; 2019; 14(11):e0224227. PubMed ID: 31747416 [TBL] [Abstract][Full Text] [Related]
13. Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats. Movassaghi M; Shabihkhani M; Hojat SA; Williams RR; Chung LK; Im K; Lucey GM; Wei B; Mareninov S; Wang MW; Ng DW; Tashjian RS; Magaki S; Perez-Rosendahl M; Yang I; Khanlou N; Vinters HV; Liau LM; Nghiemphu PL; Lai A; Cloughesy TF; Yong WH Exp Mol Pathol; 2017 Aug; 103(1):87-93. PubMed ID: 28663030 [TBL] [Abstract][Full Text] [Related]
14. Correlation of genomic alterations between tumor tissue and circulating tumor DNA by next-generation sequencing. Chang YS; Fang HY; Hung YC; Ke TW; Chang CM; Liu TY; Chen YC; Chao DS; Huang HY; Chang JG J Cancer Res Clin Oncol; 2018 Nov; 144(11):2167-2175. PubMed ID: 30203147 [TBL] [Abstract][Full Text] [Related]
15. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927 [TBL] [Abstract][Full Text] [Related]
16. Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors. Waters AM; Johnston JM; Reddy AT; Fiveash J; Madan-Swain A; Kachurak K; Bag AK; Gillespie GY; Markert JM; Friedman GK Hum Gene Ther Clin Dev; 2017 Mar; 28(1):7-16. PubMed ID: 28319448 [TBL] [Abstract][Full Text] [Related]
17. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities. Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623 [TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review. Nobusawa S; Hirato J; Yokoo H Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241 [TBL] [Abstract][Full Text] [Related]
19. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma. Preusser M; Berghoff AS; Koller R; Zielinski CC; Hainfellner JA; Liebmann-Reindl S; Popitsch N; Geier CB; Streubel B; Birner P Eur J Cancer; 2015 Sep; 51(13):1803-11. PubMed ID: 26164066 [TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Korshunov A; Ryzhova M; Hovestadt V; Bender S; Sturm D; Capper D; Meyer J; Schrimpf D; Kool M; Northcott PA; Zheludkova O; Milde T; Witt O; Kulozik AE; Reifenberger G; Jabado N; Perry A; Lichter P; von Deimling A; Pfister SM; Jones DT Acta Neuropathol; 2015 May; 129(5):669-78. PubMed ID: 25752754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]